Evaluation of the Efficacy of Panax Ginseng on Lipid Metabolism in Men and the Relationship With Sports Practice.

Sports Physical Therapy Clinical Trial

— GinsengRun  

Official title:

Evaluation of the Efficacy of Panax Ginseng on Lipid Metabolism in Men and the Relationship With Sports Practice.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03888196
• Other study ID #: Nutren-Disanta 0012018
• Status: Completed
• Phase: Early Phase 1
• Start date: September 1, 2016
• Est. completion date: January 15, 2019

Study information

• Verified date: April 2019
• Source: Universitat de Lleida
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Panax Ginseng (P ginseng), C.A. Meyer, Red, Chinese or Korean ginseng is a plant from eastern Asia and is one of the most widely used herbal products in the world. P ginseng has been been used for many years for different medical therapies. Previous studies have demonstrate that P. ginseng root extract supplementation may promote fat oxidation, increase hepatic glycogen levels and produce a glycogen-sparing and antifatigue effect during exercise in swimming rats. Notwithstanding, although there is some evidence of P. ginseng effects in humans, no evidence has been obtained respect to its supplementation in human sport performance. The aim of this study is to assess the effect of P ginseng extract supplementation on the lipid metabolism and sport performance in male endurance runners. For this purpose, the effect of supplementation for 2 weeks of 500 mg/day of P. ginseng will be evaluated in a sub-maximal physical stress test. Variables of lipid metabolism, energy consumption, fatigue, and endurance will be determined.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: January 15, 2019
• Est. primary completion date: November 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Athletic men of aerobic type, who participate in a supervised training as a previous step to the accomplishment of competitions

• Which their age is older than 18 years

• Training superior or equal to 3 days per week and that these workouts are stable during the intervention.

Exclusion Criteria:

• Athletes with high blood pressure, with pharmacological treatment for hypercholesterolemia, diabetes, any psychiatric illness

• Athletes who practice sports without having the objective of increasing sports performance

• Athletes who use some type of ergogenic sport supplementation looking to optimize any aspect related to the sport.

Related Conditions & MeSH terms

• Sports Physical Therapy

Intervention

Dietary Supplement:
• Panax Ginseng Supplementation
500 mg/day of Panax Ginseng
• Placebo Supplementation
500 mg/day of Cellulose

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Universitat de Lleida

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline plasmatic Total Lipids at 2 weeks	Total Lipids in the plasma are measured in mg / dL	2 weeks
Primary	Change from baseline plasmatic Triglycerides at 2 weeks	Triglycerides in the plasma are measured in mg / dL	2 weeks
Primary	Change from baseline Respiratory Exchange Rate at 2 weeks	To quantify the amount of Oxygen consumed and the amount of carbon dioxide produced. (mL/Kg/Min)	2 weeks